Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty (SLT): A Randomized, Masked, Placebo Controlled Study

NCT00485108 NA COMPLETED

The type of anti-inflammatory medication used post selective laser trabeculoplasty (SLT) may have an impact on the intra-ocular pressure (IOP) lowering effect of SLT. This study will evaluate the IOP lowering effect of SLT following the topical administration of one of the following: prednisolone 1%, ketorolac 0.5% or artificial tears.

Details

Lead sponsor	Queen's University
Phase	NA
Status	COMPLETED
Enrolment	120
Start date	2007-01
Completion	2014-12

Conditions

• Primary Open Angle Glaucoma
• Pseudoexfoliation Glaucoma

Interventions

• prednisolone 1%
• ketorolac 0.5%
• Artificial Tears (Methyl cellulose drops)

Primary outcomes

• Intraocular pressure lowering effect — 1 hour, 2 days, 1 month, 3 months, 6 months and 1 year

Countries

Canada